Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Breathing

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...

Respiratory Assessment: Purpose and Indications

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...

Pulmonary Cycle: Exhalation

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...

Acute Respiratory Failure-II

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

Pneumothorax-I

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.

Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen

Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen

Oxygen therapy is a pivotal aspect of medical care, particularly for patients with respiratory ailments. Two prominent oxygen-delivering systems include the Venturi mask and the transtracheal oxygen catheter.
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Machine intelligence identifies soluble TNFa as a therapeutic target for spinal cord injury.

Scientific reports·2021

Same author

Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis.

PloS one·2018

Same author

Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial.

EBioMedicine·2017

Same author

Pulmonary veno-occlusive disease in a pediatric hematopoietic stem cell transplant patient: a cautionary tale.

Leukemia & lymphoma·2017

Same author

Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.

Tuberculosis (Edinburgh, Scotland)·2015

Same author

Longitudinal development of obesity in the post-Fontan population.

European journal of clinical nutrition·2015

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice

Published on: October 20, 2013

Inhaled nitric oxide in neonates with persistent pulmonary hypertension.

W Tworetzky, J Bristow, P Moore

Lancet (London, England)

|February 24, 2001

Summary

Inhaled nitric oxide improved oxygenation in neonates with persistent pulmonary hypertension (PPHN) at 5 parts per million (ppm). However, the optimal dose for hemodynamic improvement was 20 ppm, suggesting this higher initial dose for PPHN treatment.

More Related Videos

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Related Experiment Videos

Last Updated: Jun 21, 2026

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice

Published on: October 20, 2013

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Area of Science:

Neonatal Medicine
Cardiology
Pulmonology

Background:

Persistent pulmonary hypertension of the neonate (PPHN) is a critical condition characterized by elevated pulmonary vascular resistance.
Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator used to treat PPHN.
Understanding the dose-response relationship of iNO is crucial for optimizing PPHN management.

Purpose of the Study:

To determine the dose-response effects of inhaled nitric oxide on oxygenation and hemodynamics in neonates with PPHN.
To identify the optimal iNO dosage for treating PPHN.

Main Methods:

Seven neonates diagnosed with PPHN were administered inhaled nitric oxide.
Pulmonary arterial pressure was directly measured.
Oxygenation and pulmonary-to-systemic arterial pressure ratio were assessed at varying iNO concentrations (ppm).

Main Results:

Peak improvement in oxygenation was observed at an iNO dose of 5 ppm.
The pulmonary-to-systemic arterial pressure ratio showed maximal improvement at a higher iNO dose of 20 ppm.
A dose-dependent relationship was noted for both oxygenation and hemodynamic parameters.

Conclusions:

The optimal dose of inhaled nitric oxide for improving hemodynamics in PPHN is 20 ppm.
While 5 ppm iNO improves oxygenation, a higher initial dose of 20 ppm is recommended for comprehensive treatment of PPHN.
Further studies may explore individualized iNO titration strategies based on patient response.